E. Bayerdorffer et al., CHRONIC TYPE-B GASTRITIS AS AN IMPORTANT DENOMINATOR OF PEPTIC-ULCER HEALING, European journal of gastroenterology & hepatology, 5, 1993, pp. 190000099-190000105
Objective: To examine the influence of chronic type B gastritis in duo
denal ulcer healing and the risk of duodenal ulcer relapse. Patients a
nd methods: We studied 60 patients with Helicobacter pylori-associated
duodenal ulcers who were randomly treated with either 40 mg omeprazol
e twice a day for 10 days followed by 20 mg once a day till day 42, or
a combination of omeprazole + 1 g amoxycillin twice a day for the fir
st 10 days followed by 20 mg omeprazole once a day as monotherapy unti
l day 42. Results: We followed 25 patients in the omeprazole group and
27 in the omeprazole + amoxycillin group. No patient was allowed to t
ake any anti-ulcer medication during the follow-up. The cumulative rel
apse rates within 12 months were 52% in the omeprazole group and 7% in
the omeprazole + amoxycillin group, all in patients with persistent H
. pylori infection. The 24-month cumulative relapse rates were 76 and
22%, respectively. Only two duodenal ulcer relapses occurred in patien
ts in whom H. pylori had been eradicated and these were re-infected at
the time of relapse. We studied the effects of treatment on gastritis
by measuring various parameters before treatment, at the end of treat
ment, 4 weeks after treatment, 1 year after treatment and 2 years afte
r treatment, including the extent of gastritis (infiltration by lympho
cytes and plasma cells), H. pylori colonization, gastritis activity, d
egeneration of the gastric foveolar epithelium and gastric mucus deple
tion, in two antral and two body biopsy specimens. All these parameter
s were assessed on a score of 0-4. Duodenal ulcer relapses within 24 m
onths were dependent on the gastritis score at the end of treatment (6
% 2, 61% 3, 91% 4), and on the H. pylori score 4 weeks after the end o
f the treatment (9% 0, 62% 3, 92% 4). Conclusions: The data show that
long-term eradication of H. pylori is possible with high-dose omeprazo
le + amoxycillin treatment. In the case of persistent H. pylori infect
ion, duodenal ulcer relapses depend on the extent of gastritis and the
level of H. pylori colonization.